Serum galectin-1 in patients with multiple myeloma: associations with survival, angiogenesis, and biomarkers of macrophage activation

Galectin-1 (Gal-1) is known to regulate cell signaling within the immune system and may be a target for new anticancer immune therapy. In patients with chronic lymphocytic leukemia (CLL) and classical Hodgkin lymphoma (cHL), high levels of Gal-1 within the tumor microenvironment were associated with...

Descripción completa

Detalles Bibliográficos
Autores principales: Andersen, Morten Nørgaard, Ludvigsen, Maja, Abildgaard, Niels, Petruskevicius, Irma, Hjortebjerg, Rikke, Bjerre, Mette, Honoré, Bent, Møller, Holger J, Andersen, Niels F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5388249/
https://www.ncbi.nlm.nih.gov/pubmed/28435287
http://dx.doi.org/10.2147/OTT.S124321

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5388249/
https://www.ncbi.nlm.nih.gov/pubmed/28435287
http://dx.doi.org/10.2147/OTT.S124321

Ejemplares similares